Pharma Mar dividend and valuation
Valuation
Pharma Mar paid €1.00 per share in dividends over the last 12 months (yield 1.6%). Last ex-dividend date: July 8, 2026. The P/E ratio is 16.6. The average price target of 8 analysts is €98.94.
What would Pharma Mar's dividends pay over 10 years? Work it out with the dividend calculator
Data as of November 17, 2026
Pharma Mar compared with similar companies
Pharma Mar's P/E (trailing 12 months): 16.6, +34% against the median of a group of 7 similar companies (12.4).
| Metric | Pharma Mar | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 16.6 | 12.4 | 4.60 – 17.3 | Middle |
| Forward P/E | 13.2 | 33.4 | 16.7 – 52.3 | Low |
| EV/EBITDA | 18.5 | 12.9 | 4.64 – 15.1 | High |
| Price/book | 4.76 | 3.84 | 1.74 – 4.76 | High |
| Price/sales | 4.73 | 3.64 | 2.74 – 11.6 | Middle |
| Gross margin | 93.3% | 78.3% | 59.2% – 90.5% | High |
| Operating margin | 21.3% | 12.8% | -70.7% – 40.8% | Middle |
| Net margin | 28.8% | 14.1% | 0.0% – 44.5% | Middle |
| ROE | 31.5% | 19.1% | -4.7% – 27.7% | High |
| Debt/equity | 0.30 | 0.05 | 0.02 – 0.34 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Pharma Mar: valuation over time
On the latest fiscal year's earnings (2025), Pharma Mar's P/E today is 15.2, in line with the median of its last 5 fiscal years (17.4; between 9.48 and 53.6 from 2020 to 2025). Relative to earnings, it costs about the same as in the past. The dividend yield (1.6%) is above the median of the last 7 fiscal years (1.1%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| 2025 | €74.90 | €4.30 | 17.4 | €1.00 | 1.3% |
| 2024 | €79.80 | €1.49 | 53.6 | €0.80 | 1.0% |
| 2023 | €41.08 | €0.06 | — | €0.65 | 1.6% |
| 2022 | €64.30 | €2.73 | 23.6 | €0.65 | 1.0% |
| 2021 | €57.02 | €5.13 | 11.1 | €0.65 | 1.1% |
| 2020 | €71.00 | €7.49 | 9.48 | €0.60 | 0.8% |
| 2019 | €42.84 | -€0.50 | — | €0.48 | 1.1% |
| 2018 | €13.08 | -€0.93 | — | — | — |
| 2017 | €29.76 | -€1.54 | — | — | — |
| 2016 | €32.52 | -€1.32 | — | — | — |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- €1.12B
- Enterprise value
- €1.05B
- PEG
- 0.31
- EV/revenue
- 4.42
Profitability and growth
- ROA
- 8.4%
- ROIC
- 39.0%
- Revenue growth (year over year)
- 52.6%
Financial health
- Total cash
- €176.29M
- Total debt
- €70.07M
- Current ratio
- 2.36
- Quick ratio
- 1.83
- Altman Z-Score
- 7.29
- Piotroski F-Score
- 5.00
Dividends
- Annual dividend per share
- €1.00
- Dividend yield
- 1.6%
- Payout ratio
- 25.4%
- Ex-dividend date
- July 8, 2026
Analysts and estimates
- Average price target
- €98.94
- Median price target
- €98.00
- High price target
- €120.00
- Low price target
- €80.00
- Analysts with a price target
- 8
- Consensus
- Buy
- Forward EPS
- €4.93
- EPS estimate, current year
- €2.36
Shares and trading
- Beta
- 0.44
- Average volume
- 32.84K
- Shares outstanding
- 17.25M
- Float
- 13.4M
- Institutional ownership
- 11.1%
- Insider ownership
- 21.9%
